Diagnostic dynamic contrast-enhanced magnetic resonance imaging blood-brain barrier assessment combined with plasma biomarkers for mild cognitive impairment

doi:10.5498/wjp.v15.i6.103661

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (97)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-5) series.

Item

Count

PDF

HTML

Tables (1-5)

Sum=90

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Jun 19, 2025 (publication date) through Jun 1, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Psychiatry. Jun 19, 2025; 15(6): 103661
Published online Jun 19, 2025. doi: 10.5498/wjp.v15.i6.103661

Table 3 Comparison of cerebral blood flow among three groups, mean ± SD

CBF/(mL/100 g/minute)	Right					Left
CBF/(mL/100 g/minute)	Control group (n = 55)	na-MCI group (n = 50)	a-MCI group (n = 52)	F value	P value	Control group (n = 55)	na-MCI group (n = 50)	a-MCI group (n = 52)	F value	P value
Frontal lobe	69.40 ± 3.51	70.72 ± 2.15^a^,¹	53.37 ± 2.58^a^,¹^,²	606.4	< 0.0001	63.34 ± 3.25	59.60 ± 2.27^a^,¹	48.92 ± 2.60^a^,¹^,²	390.5	< 0.0001
Temporal lobe	53.31 ± 1.85	43.40 ± 1.37^a^,¹	47.64 ± 1.42^a^,¹^,²	528.1	< 0.0001	55.66 ± 2.02	51.67 ± 1.62^a^,¹	48.89 ± 1.39^a^,¹^,²	213.7	< 0.0001
Hippocampal head	58.83 ± 2.63	51.38 ± 1.65^a^,¹	48.71 ± 1.94^a^,¹^,²	325.7	< 0.0001	53.77 ± 2.51	49.06 ± 2.20^a^,¹	49.66 ± 2.42^a^,¹	61.72	< 0.0001
Hippocampus	51.32 ± 2.15	50.16 ± 1.40^a^,¹	45.87 ± 2.09^a^,¹^,²	117.8	< 0.0001	49.78 ± 1.94	46.78 ± 1.61^a^,¹	45.10 ± 1.98^a^,¹^,²	87.63	< 0.0001
Cuneus	55.20 ± 2.68	43.33 ± 1.55^a^,¹	43.24 ± 1.64^a^,¹	607.8	< 0.0001	52.23 ± 2.41	41.69 ± 1.09^a^,¹	46.90 ± 1.54^a^,¹^,²	455.1	< 0.0001
Precuneus	52.56 ± 2.36	49.67 ± 1.20^a^,¹	44.74 ± 1.58^a^,¹^,²	256.8	< 0.0001	55.17 ± 2.26	45.37 ± 1.34^a^,¹	43.22 ± 1.50^a^,¹^,²	701.6	< 0.0001
Parietal lobe	49.91 ± 2.23	48.37 ± 1.66^a^,¹	45.13 ± 1.37^a^,¹^,²	97.41	< 0.0001	48.24 ± 1.34	45.61 ± 1.19^a^,¹	42.53 ± 0.98^a^,¹^,²	311.9	< 0.0001
Basal ganglia	70.93 ± 2.38	67.66 ± 1.75^a^,¹	60.67 ± 1.49^a^,¹^,²	394.2	< 0.0001	70.53 ± 2.25	67.42 ± 2.24^a^,¹	64.63 ± 1.74^a^,¹^,²	106.6	< 0.0001
Occipital lobe	47.98 ± 2.28	48.21 ± 1.67	45.46 ± 1.49^a^,¹^,²	35.10	< 0.0001	48.20 ± 1.62	47.61 ± 1.69	45.25 ± 1.23^a^,¹^,²	55.12	< 0.0001

^aP < 0.05.

¹P vs control group.

²P vs non-amnestic mild cognitive impairment group.

CBF: Cerebral blood flow; a-MCI: Amnestic mild cognitive impairment; na-MCI: Non-amnestic mild cognitive impairment.

Citation: Sun L, Xu MR, Zhou CY, Cao SD, Zhang XL, Guan SQ, Sang WX, Li XL. Diagnostic dynamic contrast-enhanced magnetic resonance imaging blood-brain barrier assessment combined with plasma biomarkers for mild cognitive impairment. World J Psychiatry 2025; 15(6): 103661
URL: https://www.wjgnet.com/2220-3206/full/v15/i6/103661.htm
DOI: https://dx.doi.org/10.5498/wjp.v15.i6.103661